Identification of DNA methylation of < em > CAPN10 < /em > gene changes in the patients with type 2 diabetes mellitus as a predictive biomarker instead of HbA1c, random blood sugar, lipid profile, kidney function test, and some risk factors

Conclusion. These results indicate that DNA methylation changes in the CAPN10 gene promoter region may be used as a potential predictive biomarker to diagnose T2DM; however, this study requires further data to support this evidence.PMID:37823570 | DOI:10.2478/enr-2023-0025
Source: Endocrine Regulations - Category: Endocrinology Authors: Source Type: research